Speed Innovation Happiness. Corporate Overview

Similar documents
Speed Innovation Happiness. Corporate Presentation

Presentation. March 2007

Authentication Solution for Currency Management

Indsec Securities & Finance Ltd.

Making lives better every day. This is UCB

innovation. delivered.

Leader in Pharmaceutical Films

April, 2014 GameAccount Network

peace of mind For from development to commercial supply

Industry at a Crossroads: The Rise of Digital in the Outcome-Driven R&D Organization

Tapan Ray Director General Organisation of Pharmaceutical Producers of India ALCAN PACKAGING UNIVERSITY OCT 8, LONAVALA

COM C. Rozwell

2008 Course Programs Schedule

Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

International Conference on Pharmaceutical Research and Development June 06-07, 2018 Philadelphia, USA

Aqua Pharmaceuticals, LLC

Singular ID. The Story of Commercialising a Materials Technology in Singapore. Adrian Burden

USTGlobal. How Integrated Data and Technology Affect the Healthcare Ecosystem. UST Global Healthcare Contributed Article

Siegfried at a Glance. March 2018

Implementing Quality Systems

THE LONG VIEW IN BRIEF

Information & Communication Technology Strategy

Industrial Innovation Information Days Brussels 3-4 October 2017

Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

[Overview of the Consolidated Financial Results]

Health & Social Care Industrial Innovation

ROLE OF INTELLECTUAL PROPERTY RIGHTS IN DEVELOPING COUNTRIES -ASHWINI SANDU.

Digital Health Startups A FirstWord ExpertViews Dossier Report

Pan-Canadian Trust Framework Overview

Stakeholder engagement

Annual Press Conference Financial year 2017

Q8 and Q8 annex An industry Perspective

Fortis to acquire strategic stake in Parkway Holdings, Singapore

CeQur establishes Wales subsidiary

Translational scientist competency profile

Comprehensive Research Services

New Directions for Wearables

ITI Comment Submission to USTR Negotiating Objectives for a U.S.-Japan Trade Agreement

Reduce cost sharing and fees Include other services. Services: which services are covered? Population: who is covered?

'INNOVATIVE SOLUTIONS FOR RESEARCH IN HEALTHCARE' Developing a novel approach to deliver better precision medicine in Europe The EMA standpoint

National Medical Device Evaluation System: CDRH s Vision, Challenges, and Needs

OMCL Network of the Council of Europe GENERAL DOCUMENT

NHS Next Stage Review: Innovation

B) Issues to be Prioritised within the Proposed Global Strategy and Plan of Action:

Medical Education Activities

WIPO-WASME Program on Practical Intellectual Property Rights Issues for Entrepreneurs, Economists, Bankers, Lawyers and Accountants

Pharma Clean Assurance Programme.

Timescales for Change A Look at Innovation in the Pharmaceutical Industry

Basque Country. RIS3 EUSKADI & ADVANCED MANUFACTURING STRATEGY Basque Industry 4.0

J.P. Morgan Healthcare Conference Summary Transcript

FDA Centers of Excellence in Regulatory and Information Sciences

Observations from Pharma

The #1 Partner to Gaming Operators Worldwide

the Companies and Intellectual Property Commission of South Africa (CIPC)

PHARMA S NEW PHASE. Technological integrators play as crucial a role as banks in Big Pharma s latest M&A boom. They re back.

Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum

Mara H. Rogers, Partner Norton Rose Fulbright

Communication and dissemination strategy

(Fig.) JPMA Industry Vision 2025

Creating a Vision for Health Literacy s Future: The Research Agenda

Koen Dejonckheere. Professional experience. Board Memberships. Education

Japan s FinTech Vision

Health Care and Digital in Italy. Daniela Bianco, Partner e Responsabile Health Care Unit Alessandro Viviani, Principal Expert Digital Strategy

4. Vision 2: Providing innovative drugs to 8 billion people worldwide

Cambridge Cognition. Neuroscience Digital Health. 30 January 2018

Parenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy)

Annual Shareholders' Meeting. Stuttgart May 14th 2009

MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017)

Brazilian industry s activities for international convergence. Walker Lahmann Director of External Trade at ABIFINA Executive Director at Eurofarma

Vetter. The experts in complex development, aseptic manufacturing and packaging. Facts figures data 2018

NFC Forum NFC Use Cases

Gerresheimer CAPITAL MARKETS DAY 2010

Progress in FDA s Drug Product Quality Initiative. Janet Woodcock, M.D. November 13, 2003

Lupin Limited Annual Results FY12. Investor Presentation May being

Patenting Strategies. The First Steps. Patenting Strategies / Bernhard Nussbaumer, 12/17/2009 1

Machine Vision in Austria

ACCOUNTING TREATMENT OF INTELLECTUAL PROPERTY IN THE PHARMACEUTICAL INDUSTRY

MEDIA RELEASE FOR IMMEDIATE RELEASE 4 JUNE 2014

SOLUTIONS WITH INSIGHT

Combating Counterfeit Medicines Challenges & Solutions

Inter-Association Task Force

Medical Device Usability Engineering. Product and Service Design Innovation Consultancy

EU GMP Evolution or Revolution Scope and drivers for EU GMP changes. August Gordon Farquharson

Compliance for Eucomed: The Medical Technology Industry s s Perspective

WORKING GROUP 3&5: PUBLIC-PRIVATE PARTNERSHIP

Chiyoda Corporation and Ezra Holdings Limited enter into MOU to establish 50:50 Joint Venture, EMAS CHIYODA Subsea

Feature. Accelerate Business Development Contributing to Further Enhance Ophthalmic Treatment in Asia. 2020, our goal is to become #1 in

USTR NEWS UNITED STATES TRADE REPRESENTATIVE. Washington, D.C UNITED STATES MEXICO TRADE FACT SHEET

OE-A Highlights. LOPEC 2017 Main Press Conference. March 29, 2017 ICM, Messe München. Dr. Jeremy Burroughes

PDA 71 Years of Connecting People, Science and Regulation

Patenting trends in Indian pharmaceutical industry

9 Vaccine SMEs' Needs

Automotive Sector What is our interest in CAV & ITS and Why? Nigel J Francis

AMCo current. Medpace new in Sebia realised. Spire Healthcare partially realised. Healthcare. Sector insights. Our Healthcare portfolio in 2014

Digital Financial Solutions to Advance Women s Economic Participation

DAB+ Digital Radio. Global update. Vasant Venkatramani, WorldDAB IFTV Broadcast Istanbul, November 2018

How Paediatric Research Networks can help drug development

Dammika Peiris, Senior Pharmacovigilance Manager and Head of Chugai Pharma Europe

Health Innovation Manchester

Update on Progress Implementing the LSIF Anti- Counterfeit Medicines Action Plan

Transcription:

Corporate Overview

Contents Bilcare Overview Businesses Business Strategy Financial Overview 2

Bilcare Overview 3

Bilcare Overview Our Objective Vision Delivering Innovation Transforming Lives Values Speed Innovation Happiness Proactive and swift action is our mantra Our constant approach at all levels is to seek better ways of listening, thinking and doing - making our offerings meaningful and impactful We are motivated by our customer's success and happiness of our stakeholders. 4

Bilcare Overview Business Overview Market position Revenues Customers Global Footprint People Leading provider of Research based Innovative packaging solutions USD 600 million in revenues Over 2500 customers globally Plants in 9 locations across Europe, US and Asia Team of 1800+ strong professionals globally 5

Businesses 8

Businesses Business Verticals Bilcare Solutions Global Clinical Supplies nonclonableid TM Technologies Pharma Packaging Innovations Packaging Films Solutions Accelerating drug development process Solutions for Clinical Trial Programs; facilitating speed to market Anytime, Anywhere Authentication and Trackand-Trace technology for people and products Cards Solutions Specialty Films Solutions 9

Businesses Bilcare Solutions Pharma Packaging Innovations Pioneers in providing a wide range of pharmaceutical films & foils, to suit the sensitivity of the drug and strengthen its brand equity Packaging Films Solutions Leading suppliers of wide range of rigid Mono films for Food & FMCG industry Cards Solutions High quality cores and overlays for all kind of cards for Banking, Mobile, Loyalty, Club Memberships, Casinos etc. Specialty Films Solutions High quality Films for sectors such as Printing/ Decoration, Shrink films, Visual packaging, Technical applications and Office materials 10

Businesses Global Clinical Supplies End-to-end clinical supplies management services; facilitating speed to market Bilcare GCS provides: Protocol design Regulatory compliance & patient safety Batch manufacturing Packaging design Clinical packaging and randomization Storage and global distribution Returns management Distinctive services to customers in the area of product formulation and development Opportunity to more rapidly and effectively conduct clinical trials, thereby enhancing the speed to market of pharmaceutical products 11

Businesses nonclonableid TM Technologies Anytime, Anywhere Authentication and Track-and- Trace technology for people and products. Wide range of Applications Security & ID Cards Document Security Currency Security Pharmaceutical Medical Compliance Agrochemicals High-value components Fashion & Luxury goods nonclonableid TM Benefits Better visibility throughout the supply chain Reliable brand and asset protection Real-time authentication Efficient Inventory management Prevents product diversion and entry of fake products in the supply chain 12

Businesses nonclonableid TM Technologies Authentication and Track n Trace Anytime, Anywhere How is it made? How does it work? 13

Business Strategy 14

Business Strategy Addressing Challenges Compliance Counterfeit Communication Bilcare Packaging Solutions Convenience Cost Global Clinical Supplies Regulatory hurdles R&D and Innovation pipeline deficit Lack of patient population for enrollment Brand Protection Lack of Authentication tools nonclonableid TM Technologies Revenue & Profit leakages Security threats 15

Financial Overview 16

Thank you! visit us at www.bilcare.com 19